Your session is about to expire
← Back to Search
Radiation Therapy
SBRT for Breast Cancer
N/A
Recruiting
Led By Danny Vesprini, MD, FRCPC
Research Sponsored by Toronto Sunnybrook Regional Cancer Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years post treatment
Awards & highlights
Study Summary
This trial will study if SBRT is an effective treatment for 24 patients with unresectable breast cancer.
Eligible Conditions
- Breast Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years post treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years post treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acute toxicity
Secondary outcome measures
Breast Symptom Scores
Patient Reported Pain Level
Patient Reported Quality of Life
+1 moreSide effects data
From 2024 Phase 2 trial • 57 Patients • NCT0300418321%
Fatigue
13%
Nausea
11%
Back pain
9%
Shortness of Breath
9%
Anemia
9%
Abdominal pain
9%
Diarrhea
7%
Kidney Injury and/or Infection
7%
Pneumonia
7%
Dyspnea
7%
Weight Loss
5%
Malnutrition, Hypercalcemia and Weakness
5%
Pneumothorax
5%
Activated partial thromboplastin time prolonged
5%
Intractable pain, back pain, hip pain
4%
Pleural effusion
4%
Atrial fibrillation with rapid ventricular response
2%
Skin rash
2%
Thrombocytopenia
2%
Respiratory failure
2%
colitis
100%
80%
60%
40%
20%
0%
Study treatment Arm
Single Arm
Trial Design
1Treatment groups
Experimental Treatment
Group I: SBRT to the Primary Breast TumourExperimental Treatment1 Intervention
SBRT to the breast using 4 sequentially escalating dose levels from 9Gy to 12 Gy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SBRT
2014
Completed Phase 2
~1060
Find a Location
Who is running the clinical trial?
Toronto Sunnybrook Regional Cancer CentreLead Sponsor
9 Previous Clinical Trials
929 Total Patients Enrolled
1 Trials studying Breast Cancer
30 Patients Enrolled for Breast Cancer
Danny Vesprini, MD, FRCPCPrincipal InvestigatorSunnybrook Health Sciences Centre, University of Toronto
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there opportunities for prospective participants to join this research endeavor?
"Affirmative. Clinicaltrials.gov records indicate that this medical trial is actively seeking participants, with the first posting on July 17th 2018 and an update dated to May 5th 2022. 24 individuals are being sought from one research centre for recruitment into the study."
Answered by AI
How many participants are being recruited for this research endeavor?
"Affirmative. Clinicaltrials.gov indicates that this research study is recruiting patients, which began on July 17th 2018 and was last updated on May 5th 2022. 24 participants are being sought from one clinical centre."
Answered by AI
Share this study with friends
Copy Link
Messenger